G1 Therapeutics reports positive results for cancer therapy
G1 Therapeutics reports positive top-line data from a Phase 2a trial of its potential therapy for patients who are taking chemotherapy for small-cell lung cancer.
Read Morecancer research
Major investor sells $2.6M in G1 Therapeutics stock
Posted by WRAL TechWire | Dec 7, 2017
MedImmune Ventures, a significant investor in G1 Therapeutics, has sold $2.6 million worth of its stake.
Read More
